| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 16 Jun 2022 | 25 Feb 2022 | 16 Jun 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers Filling date: 8 Sep 2025 Issue date: 14 Jun 2022 | 10 Dec 2021 | 14 Jun 2022 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 14 Jun 2022 | 17 Sep 2021 | 14 Jun 2022 |
| Utility: PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS Filling date: 8 Sep 2025 Issue date: 9 Jun 2022 | 18 Feb 2022 | 9 Jun 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 7 Jun 2022 | 2 Sep 2021 | 7 Jun 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 2 Jun 2022 | 11 Feb 2022 | 2 Jun 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 31 May 2022 | 2 Sep 2021 | 31 May 2022 |
| Utility: PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS Filling date: 8 Sep 2025 Issue date: 26 May 2022 | 11 Feb 2022 | 26 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 26 May 2022 | 4 Feb 2022 | 26 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 19 May 2022 | 4 Feb 2022 | 19 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 19 May 2022 | 28 Jan 2022 | 19 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 19 May 2022 | 28 Jan 2022 | 19 May 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 8 Sep 2025 Issue date: 17 May 2022 | 1 Oct 2021 | 17 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 12 May 2022 | 28 Jan 2022 | 12 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 12 May 2022 | 21 Jan 2022 | 12 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 12 May 2022 | 21 Jan 2022 | 12 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 12 May 2022 | 21 Jan 2022 | 12 May 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 8 Sep 2025 Issue date: 10 May 2022 | 15 Oct 2021 | 10 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 5 May 2022 | 14 Jan 2022 | 5 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 5 May 2022 | 14 Jan 2022 | 5 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 5 May 2022 | 3 Dec 2021 | 5 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 5 May 2022 | 3 Dec 2021 | 5 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 5 May 2022 | 18 Nov 2021 | 5 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 5 May 2022 | 12 Nov 2021 | 5 May 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 28 Apr 2022 | 14 Jan 2022 | 28 Apr 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 28 Apr 2022 | 7 Jan 2022 | 28 Apr 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 21 Apr 2022 | 7 Jan 2022 | 21 Apr 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 21 Apr 2022 | 22 Dec 2021 | 21 Apr 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 21 Apr 2022 | 3 Dec 2021 | 21 Apr 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 21 Apr 2022 | 5 Nov 2021 | 21 Apr 2022 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 21 Apr 2022 | 1 Nov 2021 | 21 Apr 2022 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LEUKEMIAS AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 21 Apr 2022 | 23 Jun 2021 | 21 Apr 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 14 Apr 2022 | 23 Dec 2021 | 14 Apr 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 14 Apr 2022 | 17 Dec 2021 | 14 Apr 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 14 Apr 2022 | 29 Oct 2021 | 14 Apr 2022 |
| Utility: AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 8 Sep 2025 Issue date: 14 Apr 2022 | 29 Sep 2021 | 14 Apr 2022 |
| Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer Filling date: 8 Sep 2025 Issue date: 12 Apr 2022 | 1 Oct 2021 | 12 Apr 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 7 Apr 2022 | 17 Dec 2021 | 7 Apr 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 7 Apr 2022 | 17 Dec 2021 | 7 Apr 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 7 Apr 2022 | 11 Jun 2021 | 7 Apr 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 5 Apr 2022 | 16 Jul 2021 | 5 Apr 2022 |
| Utility: T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME AGAINST PRAME POSITIVE CANCERS Filling date: 8 Sep 2025 Issue date: 31 Mar 2022 | 16 Dec 2021 | 31 Mar 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 31 Mar 2022 | 10 Dec 2021 | 31 Mar 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 31 Mar 2022 | 10 Dec 2021 | 31 Mar 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 31 Mar 2022 | 10 Dec 2021 | 31 Mar 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 22 Mar 2022 | 9 Jul 2021 | 22 Mar 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 22 Mar 2022 | 9 Jul 2021 | 22 Mar 2022 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 22 Mar 2022 | 30 Apr 2021 | 22 Mar 2022 |
| Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer Filling date: 8 Sep 2025 Issue date: 15 Mar 2022 | 24 Sep 2021 | 15 Mar 2022 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 3 Mar 2022 | 18 Nov 2021 | 3 Mar 2022 |
